Cancer Cachexia Clinical Trial
Official title:
A Pilot Bioimaging Trial of Cancer Cachexia
This is a pilot trial using 18F-FDG PET and DXA scans to determine whether these investigations are objective tools to assess cachexia.
This pilot study will establish the differences in BAT uptake of 18F-FDG in cachectic and non-cachectic cancer patients using PET imaging. Patients willbe assessed for sarcopenia using a dual energy X-ray absorptiometry or bone densitometry scan (DXA). Given the variables which may affect uptake of BAT in cancer patients, this study will standardise patient preparation and PET scan procedure in order to obtain the most reliable assessment of BAT activity in all patients on study. It is hypothesisd that use of this PET imaging technique, which is part of standard care to assess cancer progression, may assist clinicians in early identification of metabolic changes in a patient, with potential for early intervention and utility in monitoring success of treatments of cachexia. A total of 40 patients will be evaluated, 20 patients with advanced/metastatic colorectal, non-small cell lung cancer (NSCLC) or pancreatic cancer without cachexia, and 20 patients with advanced/metastatic colorectal, non-small cell lung cancer (NSCLC), or pancreatic cancer with documented cachexia, all of whom are referred for standard of care 18F-FDG PET scans. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02553187 -
A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia
|
Phase 4 | |
| Recruiting |
NCT02848807 -
Chemotherapy-related Toxicity, Nutritional Status and Quality of Life
|
N/A | |
| Active, not recruiting |
NCT01206335 -
Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia
|
Phase 2 | |
| Completed |
NCT00378131 -
Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia
|
Phase 2 | |
| Completed |
NCT02359123 -
Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients
|
N/A | |
| Completed |
NCT00267358 -
Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.
|
Phase 2 | |
| Completed |
NCT03144128 -
Vitamin D for Muscle Metabolic Function in Cancer Cachexia
|
N/A | |
| Completed |
NCT01614990 -
Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia
|
Phase 2 | |
| Recruiting |
NCT04065815 -
Protein-rich Nutritional Therapy Combined With Time-efficient Exercise in Cancer Therapy
|
N/A | |
| Recruiting |
NCT04067167 -
Flexi Band Resistance Training Versus EMS Exercise in Patients With the Diagnosis of Malignant Diseases
|
N/A | |
| Active, not recruiting |
NCT03851133 -
Florida Pancreas Collaborative Next Generation Biobank
|
||
| Completed |
NCT05264038 -
A First in Human Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics Effects of OC514
|
Phase 1 | |
| Not yet recruiting |
NCT05262192 -
Nutrition Education and Quality of Life in Cancer Cachexia
|
N/A | |
| Completed |
NCT04153019 -
PSYCHO-EDUCATIONAL AND REHABILITATIVE INTERVENTION FOR CANCER CACHEXIA (PRICC)
|
N/A | |
| Terminated |
NCT02066363 -
Study of Parenteral Nutrition to Patients With Gastrointestinal Cancer
|
N/A | |
| Terminated |
NCT01505764 -
The Role of Ghrelin in Cancer Cachexia
|
Phase 2 | |
| Completed |
NCT00219817 -
Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss
|
Phase 2 | |
| Completed |
NCT00094562 -
A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss
|
Phase 2 | |
| Recruiting |
NCT04131478 -
Effect of Gene Polymorphisms on the Pathogenesis of Cancer Cachexia
|
||
| Recruiting |
NCT05915325 -
Physical Training for Elderly Cancer Patients With Cachexia
|
N/A |